Cardiac Imaging

Which Imaging Study Is Best for Suspected Recurrent Pulmonary Embolism?

·
Which Imaging Study Is Best for Suspected Recurrent Pulmonary Embolism?

A 58-year-old male presents to your clinic with two weeks of progressive, vague pleuritic chest pain and mild dyspnea on exertion. Four months ago, he was diagnosed with an acute pulmonary embolism (PE) and has been reportedly compliant with his direct oral anticoagulant. His vital signs are stable, but his symptoms are concerning. Is this a new embolic event, incompletely resolved disease, or something else entirely? This article provides a detailed clinical workflow for selecting the appropriate initial imaging study in an adult with a known history of PE who now has suspected recurrent or residual disease. For this specific presentation, the American College of Radiology (ACR) Appropriateness Criteria rate MRA chest with IV contrast as Usually Appropriate.

Who Fits This Clinical Scenario for Suspected Recurrent Pulmonary Embolism?

This guidance is for a specific patient population: an adult with a previously confirmed diagnosis of acute pulmonary embolism who is now presenting with new or worsening symptoms suggestive of a new clot or complications from the old one. These symptoms often include dyspnea, pleuritic chest pain, tachycardia, or decreased exercise tolerance. The core of the scenario is the pre-existing diagnosis, which fundamentally changes the imaging strategy from a de novo workup.

This workflow does not apply to several similar-appearing but distinct clinical situations:

  • Initial PE Diagnosis: This guidance is not for patients with a first-time suspicion of PE and no prior history. That workup follows a different diagnostic algorithm, often starting with risk stratification scores and D-dimer testing.
  • Established Chronic Thromboembolic Disease: This article is not for patients with a known, established diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) who are undergoing routine surveillance. That scenario, detailed in the sibling ACR variant “Adult. Known chronic thromboembolic disease. Surveillance,” involves different imaging goals.
  • Hemodynamic Instability: Patients who are hemodynamically unstable (e.g., hypotensive, in shock) with suspected PE require an emergent workup where the speed and availability of imaging, such as bedside echocardiography or immediate CT angiography, are paramount and may override other considerations.

What Diagnoses Are You Working Up in This Scenario?

When a patient with a history of PE presents with new cardiorespiratory symptoms, the differential diagnosis is focused but critical. The choice of imaging is intended to differentiate among these possibilities.

Recurrent Acute Pulmonary Embolism: This is the most urgent consideration. Despite anticoagulation, a new thrombus may have formed and embolized to the lungs. This could be due to subtherapeutic medication levels, non-adherence, an underlying hypercoagulable state, or malignancy. Imaging must be sensitive enough to detect new, acute clot.

Residual Thrombus or Incomplete Resolution: The original clot from the initial event may not have fully dissolved. This persistent clot burden can cause ongoing symptoms and is a key factor to assess. The imaging goal is to distinguish this older, potentially organizing thrombus from a fresh, acute embolus.

Chronic Thromboembolic Pulmonary Hypertension (CTEPH): This is a serious long-term complication where unresolved emboli organize into fibrous webs and strictures within the pulmonary arteries. This obstruction increases pulmonary vascular resistance, leading to pulmonary hypertension and right heart failure. While this scenario is for suspected recurrence, identifying early signs of chronic disease is a crucial secondary goal of the imaging study.

Post-PE Syndrome: Some patients experience persistent dyspnea, fatigue, and reduced quality of life after an acute PE, even with clear imaging and normal hemodynamics. This is a diagnosis of exclusion, making it essential to first rule out the more dangerous causes of recurrent or residual disease with appropriate imaging.

Why Is MRA Chest with IV Contrast a Recommended Study for Suspected Recurrent PE?

For a patient with a known PE history, the imaging choice balances diagnostic accuracy with considerations like cumulative radiation exposure. The ACR designates several studies as Usually Appropriate, including MRA, CTA, and V/Q scanning, each with distinct advantages for this specific scenario.

Magnetic Resonance Angiography (MRA) of the chest with IV contrast is an excellent choice because it provides detailed visualization of the pulmonary vasculature without using ionizing radiation (adult relative radiation level: O, 0 mSv). This is a significant benefit for patients who may require multiple follow-up scans over their lifetime. MRA has high diagnostic accuracy for detecting both acute emboli and the more subtle signs of chronic disease, such as arterial webs, bands, and stenoses, which are crucial in this patient population.

Comparing MRA to the other Usually Appropriate options reveals key trade-offs:

  • CTA pulmonary arteries with IV contrast: This is also Usually Appropriate and is often faster and more widely accessible than MRA. It provides superb anatomical detail. However, it delivers a notable dose of ionizing radiation (adult RRL: ☢☢☢, 1-10 mSv). For a younger patient or one with conditions requiring serial imaging, minimizing this cumulative dose is a primary reason to consider MRA first.
  • V/Q scan lung: Also rated Usually Appropriate, a ventilation/perfusion scan is highly sensitive for PE and often involves a lower radiation dose than CTA. Its strength is its high negative predictive value. However, it can be non-diagnostic in patients with underlying lung disease (e.g., COPD) and provides less direct anatomical information about clot burden or the features of chronic thromboembolic disease compared to MRA or CTA.

When ordering, be sure to specify the indication as “suspected recurrent/residual pulmonary embolism” to ensure the radiology department performs the correct MRA sequences, such as first-pass perfusion imaging. The study requires a gadolinium-based contrast agent, so standard screening for severe renal impairment is necessary.

What’s the Next Step After an MRA for Suspected Recurrent PE?

The results of the MRA guide the subsequent clinical workflow, which diverges significantly based on the findings.

If the MRA is positive for recurrent acute PE: This finding indicates a failure of the current treatment plan. The immediate next step is a thorough re-evaluation of the patient’s anticoagulation. This may involve assessing adherence, checking drug levels if applicable, and potentially switching to a different class of anticoagulant (e.g., from a DOAC to a vitamin K antagonist or low-molecular-weight heparin). A workup for an underlying prothrombotic condition or occult malignancy may also be warranted.

If the MRA is positive for chronic thromboembolic disease (CTEPH): If the study shows signs of organized thrombus, arterial webs, or right ventricular strain, the patient’s diagnosis shifts from acute recurrence to a long-term complication. The next step is a referral to a specialized pulmonary hypertension center for further evaluation, which typically includes a V/Q scan (often considered the best screening test for CTEPH) and right heart catheterization to confirm the diagnosis and quantify the severity of pulmonary hypertension.

If the MRA is negative: A negative, high-quality MRA effectively rules out significant recurrent or residual embolic disease. The focus should shift to investigating other causes for the patient’s symptoms, such as cardiac, primary pulmonary, or musculoskeletal conditions. If symptoms persist without a clear explanation, the diagnosis may be post-PE syndrome, which is managed symptomatically.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup for suspected recurrent PE requires careful attention to detail to avoid common errors. A primary pitfall is ordering a non-dedicated imaging study, such as a routine “CT chest with contrast,” instead of a specific “CTA for pulmonary arteries.” The timing and bolus tracking for a PE protocol are critical for proper opacification of the pulmonary arteries and cannot be substituted.

Another error is failing to consider the patient’s renal function before ordering a contrast-enhanced study, whether it is a CTA or MRA. Always check a recent creatinine and eGFR. Finally, be cautious not to dismiss persistent symptoms after a negative study. If clinical suspicion remains high or the patient’s condition worsens, do not hesitate to escalate. If the MRA findings are equivocal or discordant with the clinical picture, a direct consultation with the interpreting radiologist or a pulmonologist is the appropriate next step.

Related ACR Topics and Tools

The ACR Appropriateness Criteria are a living resource, and understanding how this specific scenario fits into the broader context is essential for sound clinical decision-making. For a comprehensive overview of all clinical variants related to imaging after a known PE, please consult our parent topic guide. Additionally, GigHz offers several tools to support evidence-based imaging orders.

Frequently Asked Questions

Why is MRA preferred over CTA if both are ‘Usually Appropriate’ for suspected recurrent PE?

While both are excellent studies, MRA is often preferred in this specific scenario to avoid ionizing radiation. Patients with a history of PE may require multiple imaging studies over their lifetime, and minimizing cumulative radiation dose is an important long-term consideration, especially in younger patients. MRA provides comparable diagnostic information without any radiation exposure.

What if my institution has limited or no access to MRA for pulmonary embolism?

If MRA is not readily available, CTA of the pulmonary arteries is an excellent and highly effective alternative that is also rated ‘Usually Appropriate’ by the ACR. It is fast, widely available, and provides superb anatomical detail. The choice between MRA, CTA, and V/Q scan often comes down to local expertise, availability, and patient-specific factors like radiation concerns or contrast allergies.

Is a D-dimer test useful in a patient with a known PE history and suspected recurrence?

The utility of a D-dimer test is significantly reduced in this context. D-dimer is most useful for ruling out a first-time PE in low-risk patients. In someone with a known history of PE, a D-dimer is likely to be non-specific and can be elevated for numerous reasons, including the presence of residual clot. Therefore, it is generally not recommended to guide the decision to pursue imaging in this scenario.

If the MRA shows signs of chronic PE, is the patient’s anticoagulation stopped?

No. Patients with chronic thromboembolic disease that progresses to CTEPH require lifelong therapeutic anticoagulation to prevent new clots from forming on top of the existing organized thrombus. The diagnosis of CTEPH opens up additional treatment avenues, such as pulmonary thromboendarterectomy or balloon pulmonary angioplasty, but anticoagulation remains a foundational part of their management.

Can a transthoracic echocardiogram (TTE) be used instead of MRA or CTA?

A TTE is rated as ‘May be appropriate’ but serves a different purpose. It cannot directly visualize clots in the pulmonary arteries. Its role is to assess for signs of right heart strain (e.g., right ventricular dilation or dysfunction), which can be an indirect sign of a significant PE. It is a useful tool, especially at the bedside in an unstable patient, but it is not a substitute for definitive vascular imaging like MRA or CTA to diagnose or rule out recurrent PE.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026